BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.30−0.02 (-1.52%)
Close on Nov 20, 2026Market cap $29.47MP/E –Yield –
BioHarvest Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$5.58M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.58M | – |
| FY2024 | Dec 31, 2024 | -$6.99M | – |
| FY2023 | Dec 31, 2023 | -$9.97M | – |
See a number that looks wrong?